scholarly journals Saxagliptin Efficacy and Safety in Patients With Type 2 Diabetes and Moderate Renal Impairment

2016 ◽  
Vol 7 (3) ◽  
pp. 527-535 ◽  
Author(s):  
Shira Perl ◽  
William Cook ◽  
Cheryl Wei ◽  
Nayyar Iqbal ◽  
Boaz Hirshberg
Keyword(s):  
Type 2 Diabetes ◽  
Renal Impairment ◽  
Moderate Renal Impairment ◽  
Efficacy And Safety

136-LB: Efficacy and Safety of Sotagliflozin (SOTA) in Patients with Type 2 Diabetes (T2D) and Moderate Renal Impairment

Diabetes ◽  
2020 ◽  
Vol 69 (Supplement 1) ◽  
pp. 136-LB
Author(s):  
DAVID CHERNEY ◽  
ELE FERRANNINI ◽  
GUILLERMO E. UMPIERREZ ◽  
ANNE L. PETERS ◽  
JULIO ROSENSTOCK ◽  
...  
Keyword(s):  
Type 2 Diabetes ◽  
Renal Impairment ◽  
Moderate Renal Impairment ◽  
Efficacy And Safety

scholarly journals Efficacy and safety of oral semaglutide in patients with type 2 diabetes and moderate renal impairment (PIONEER 5): a placebo-controlled, randomised, phase 3a trial

2019 ◽  
Vol 7 (7) ◽  
pp. 515-527 ◽  
Author(s):  
Ofri Mosenzon ◽  
Thalia Marie Blicher ◽  
Signe Rosenlund ◽  
Jan W Eriksson ◽  
Simon Heller ◽  
...  
Keyword(s):  
Type 2 Diabetes ◽  
Renal Impairment ◽  
Moderate Renal Impairment ◽  
Efficacy And Safety

scholarly journals Efficacy and safety of dapagliflozin in patients with type 2 diabetes and moderate renal impairment (chronic kidney disease stage 3A): The DERIVE Study

2018 ◽  
Vol 20 (11) ◽  
pp. 2532-2540 ◽  
Author(s):  
Paola Fioretto ◽  
Stefano Del Prato ◽  
John B. Buse ◽  
Ronald Goldenberg ◽  
Francesco Giorgino ◽  
...  
Keyword(s):  
Type 2 Diabetes ◽  
Chronic Kidney Disease ◽  
Kidney Disease ◽  
Renal Impairment ◽  
Chronic Kidney Disease Stage ◽  
Moderate Renal Impairment ◽  
Disease Stage ◽  
Efficacy And Safety

1004-P: Oral Semaglutide vs. Placebo in Patients with Type 2 Diabetes and Moderate Renal Impairment: PIONEER 5

Diabetes ◽  
2019 ◽  
Vol 68 (Supplement 1) ◽  
pp. 1004-P ◽  
Author(s):  
OFRI MOSENZON ◽  
SIGNE ROSENLUND ◽  
JAN W. ERIKSSON ◽  
SIMON R. HELLER ◽  
RICHARD E. PRATLEY ◽  
...  
Keyword(s):  
Type 2 Diabetes ◽  
Renal Impairment ◽  
Moderate Renal Impairment

scholarly journals Glycemic Control and Hypoglycemia Benefits with Insulin Glargine 300 U/mL (Gla-300) Extend to People with Type 2 Diabetes and Mild-to-Moderate Renal Impairment

2016 ◽  
Vol 40 (5) ◽  
pp. S47
Author(s):  
Peter A. Senior ◽  
Javier Escalada ◽  
Serge Halimi ◽  
Mireille Bonnemaire ◽  
Anna M.G. Cali ◽  
...  
Keyword(s):  
Type 2 Diabetes ◽  
Glycemic Control ◽  
Renal Impairment ◽  
Insulin Glargine ◽  
Moderate Renal Impairment
Sign in / Sign up

Export Citation Format

Share Document